Placement
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Control Bionics Ltd. has announced the completion of agreements to place shares, pending shareholder approval at the upcoming AGM. If approved, this placement will raise new capital and involve the issuance of fully paid ordinary shares along with attaching options. The proceeds from the placement are intended for software development, product design, and working capital.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/placement-59
Story so far
Earlier from Control Bionics
- Non-renounceable rights issue offer and private placement ad
- Non-Renounceable Issue
- Investor Presentation
- Trading Halt
- Exclusive UK and Ireland Distribution Agreement
Later from Control Bionics
- Addendum to notice of 2024 AGM
- Significant increase in revenue from faster NDIS approvals
- Coffee Microcaps Meeting Presentation
- Expansion into US Sports and Japanese Rehab Markets
- First Half FY25 Business Update
Follow Control Bionics into a list and get an email when it puts out news.
Follow Control Bionics